June 29, 2010

President and CEO Alex Chenchik gave a talk at Biocat, the Cellecta distributor in Germany, announcing a new Genetic Screen Platform and the Discovery of Drug Targets in Cancer Cell Models. (presentation)

June 23, 2010

President and CEO Alex Chenchik gave a talk at The Institut Curie, announcing a new Genetic Screen Platform and the Discovery of Drug Targets in Cancer Cell Models. (presentation)

June 6-11, 2010

2010 Gordon Conference on Mammary Gland Biology, Lucca (Barga), Italy (poster)
The latest HT RNAi screening data was presented at the Gordon Conference on Mammary Gland Biology in Lucca (Barga), Italy.

April 17-22, 2010

AACR 2010, Washington, D.C. (exhibit booth #911)
Cellecta showcased the latest pooled shRNA and peptide library technology at exhibit booth #911 at the 2010 AACR Annual Meeting in Washington, D.C.

April 20-22, 2010

BIO-IT World 2010, Boston, MA (poster)
Cellecta presented a poster on "RNAi Genetic Screens Utilizing Bar-Code HT Sequencing" in Track 3, Bioinformatics and Next-Gen Data.

April, 2010

View our company brochure for an overview of Cellecta's RNAi Screening and related services.

April 7-9, 2010

The 2010 Illumina User Symposium, Napa, CA (poster)
Cellecta President & CEO Alex Chenchik presented a poster on "RNAi Genetic Screens Utilizing Bar-Code HT Sequencing."

February 28 - March 5, 2010

2010 Gordon Conference on the Chemistry & Biology of Peptides, Ventura, CA (poster)
Cellecta introduced our latest peptide screening technology and data at the Gordon Conference on the Chemistry & Biology of Peptides in Ventura, CA.

February 3-4, 2010

Molecular Medicine TRI Conference, South S.F., CA (Poster)
Meet with one of our HT RNAi Screen Senior Scientists at the 2010 Molecular Medicine TRI Conference held in South San Francisco, CA. Cellecta will present a poster on "Ultra-HT RNAi Genetic Screens with Pooled Lentiviral shRNA HT-Seq Libraries."

December 6-8, 2009

Cellecta's scientists presented the newest RNAi and bioactive peptide screening services at booth 225 at the 2009 ASCB Annual Meeting in the San Diego Convention Center.

November 2-3, 2009

Cellecta presented a poster highlighting the most recent HT RNAi screening data, including a TGF-beta positive screen and a blood cell viability screen, at CHI's Discovery on Target RNAi For Screening Conference held in Boston, MA.

September 13-18, 2009

Cellecta presented a poster with the latest RNAi and peptide screening data at the Gordon Conference on Stem Cells & Cancer held in Les Diablerets, Switzerland.

September 10-12, 2009

Cellecta presented its RNAi and peptide screening capabilities at the EMBO Molecular Medicine Workshop '09 held in Torino, Italy.

September 10-11, 2009

The NIH NCI hosted the "Circulating Tumor Cells (CTCs): Emerging Technologies for Detection, Diagnosis and Treatment" Conference in Bethesda, MD, and Cellecta has been invited to present a poster about its RNAi and peptide screening capabilities.

June 23, 2009

Cellecta research scientist Debbie Deng was a guest speaker at the 2009 World Cancer Congress held in Beijing, China. The topic was "New Technologies for RNAi Screening with Pooled Lentiviral shRNA Libraries" and was presented at 14:30 in Track 3-5, Rational Drug Design vs. High Throughput Cancer Drug Screening.

June 9, 2009

The President/CEO of Cellecta, Alex Chenchik, Ph.D., was a guest speaker at the CHI Business of Genomics Summit at the Fairmont Hotel in San Francisco, CA. The topic was "HTS of Peptide Pharmaceuticals in the Post-Genome Era", and Dr. Chenchik spoke at 4:45pm in the Entrepreneur/Emerging Company Showcase. Please contact us if you would like to receive the presentation.

June 8-10, 2009

Cellecta presented a poster discussing the latest HT RNAi screening data at the CHI RNA Interference Summit held at the Fairmont Hotel in San Francisco, CA.

April 26-30, 2009

Cellecta's guest speaker presented research results on "High Throughput Screening for Bioactive Peptides" at the SBS 15th Annual Conference & Exhibition held in Lille Grand Palais, Lille, France. Please contact us if you would like to receive the presentation.

April 18-22, 2009

Scientists showcased Cellecta's custom research service portfolio at booth #1759 at the 100th Annual AACR Meeting in Denver, Colorado.

March 23-25, 2009

Scientists from Cellecta attended the Discovery 2009 Summit in Monte Carlo, Monaco to meet with top level executives of pharmaceutical companies and discuss RNAi screening strategies.

March 17-19, 2009

Cellecta's bioinformatics scientist presented a poster at the Next Generation Sequencing Platforms and Progress Conference in San Diego, CA.

January and March, 2009

See our print advertisements in both the January and March 2009 issues of Nature Reviews Drug Discovery. View the latest ad (PDF) >

February 25-27, 2009

Cellecta attended the 2009 Molecular Medicine Tri-Conference in San Francisco, CA and presented the latest RNAi screening data in a poster presentation.

October 21-22, 2008

Scientists from Cellecta present the latest technologies at the CHI Discovery on Target RNAi For Screening Conference at the World Trade Center in Boston, MA.

September, 2008

See our print advertisement in the September issue of Nature Reviews Drug Discovery. View the ad (PDF) >

June 23-25, 2008

At the IBC Cell Line Development and Engineering Conference held in San Diego, CA, Cellecta presents its research results on the "Development of Recombinant Protein Overproducer Cell Lines with Lentiviral Expression Vectors" using highly efficient and cost effective lentiviral technology. Download the poster presentation (PDF, 0.8MB).

March 25-30, 2008

Cellecta presented functional screening data at the Keystone RNAi, MicroRNA, and Non-Coding RNA Meeting in Whistler, British Columbia.

December 17, 2007

Cellecta presents its technology portfolio and proposal to NIH at the Request for Information (RFI) Meeting for RNAi Technologies. GenomeWeb has more information on the outcome of the meeting.

September 16, 2009

Cellecta issued a press release announcing that the company has been awarded a subcontract to assist the scientists at Roswell Park Cancer Institute and Health Research, Inc. in developing a new technology for the discovery of cancer-related genes using HT insertional mutagenesis. Download the full press release as published on PRWEB.

September 1, 2009

Cellecta is featured on goBalto under the following categories: Biological Products > Cell and Tissue Products, Recombinant Plasmid DNA, and Recombinant Virus; Preclinical and Nonclinical Services > Research and Development and Target Identification; and Pharmaceutical & Biotech > High Throughput Screening. goBalto is the fastest growing partnering site for drug discovery and development professionals on the web.

July 1, 2009

Cellecta receives three NIH SBIR Phase I Grant awards to identify novel drugs and drug targets:

• Identification of Hematopoietic Stem and Progenitor Cell Viability Genes, Grant # 1R43CA141848-01
• Drug Targets of Heat Shock Response, Grant # 1R43CA141855-01
• Inhibitors of Heat Shock Response, Grant # 1R43CA141883-01

June 10, 2009

Cellecta announces the launch of its new website.

September 25, 2008

Cellecta receives an NIH SBIR Phase I Grant award (1R43CA132841-01) for the development of an "Array-assisted Insertional Mutagenesis Platform for Forward Genetics of Cancer".

August 15, 2008

Cellecta receives an NIH SBIR Phase I Grant award (1R43CA134062-01) for the development of "Viability Pathway Models in Prostate Cancer Cells".

May 22, 2008

Cellecta is now accepting collaborations, helping accelerate your research and working towards joint NIH grants. Proposals may involve generation of custom shRNA libraries for functional screens, performing functional screens, creating knockdown or overexpression cell lines, or something new.

May 12, 2008

Cellecta partners with Ariadne to launch a Pathway Analysis service, in which we organize your functional screen data in a logical graphical format.

October 1, 2007

Cellecta receives an NIH SBIR Phase II Grant award (2R44HG003355-02) for the development of an algorithm and genome-wide database of functional siRNAs.

August 15, 2007

Sigma-Aldrich and Cellecta begin a collaboration to determine all functional shRNA in Sigma's shRNA collection.

July 1, 2007

Cellecta receives two NIH SBIR Phase I Grant awards (1R43RR024095-01 and 1R43RR024323-01). The topics are the generation of functionally-validated lentiviral shRNA libraries and the development of high throughput screening methods for peptide pharmaceuticals.

June 1, 2007

Cellecta officially begins operations in Mountain View, CA.

April 25, 2006

Cellecta, Inc. is founded by one of the chief scientists from Clontech Laboratories.